PENUMBRA INC (PEN) Stock Fundamental Analysis
USA - NYSE:PEN - US70975L1070 - Common Stock
255.6 USD
-2.15 (-0.83%)
255.6 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to PEN. PEN was compared to 191 industry peers in the Health Care Equipment & Supplies industry. PEN has an excellent financial health rating, but there are some minor concerns on its profitability. PEN is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make PEN suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year PEN was profitable.
PEN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PEN reported negative net income in multiple years.
In multiple years PEN reported negative operating cash flow during the last 5 years.
1.2 Ratios
PEN has a better Return On Assets (8.82%) than 92.67% of its industry peers.
PEN has a Return On Equity of 11.41%. This is amongst the best in the industry. PEN outperforms 87.96% of its industry peers.
PEN has a Return On Invested Capital of 7.05%. This is amongst the best in the industry. PEN outperforms 82.72% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PEN is significantly below the industry average of 8.46%.
The 3 year average ROIC (2.98%) for PEN is below the current ROIC(7.05%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 11.41% | ||
| ROIC | 7.05% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
PEN's Profit Margin of 11.54% is amongst the best of the industry. PEN outperforms 86.39% of its industry peers.
PEN's Profit Margin has declined in the last couple of years.
PEN has a better Operating Margin (12.45%) than 79.58% of its industry peers.
In the last couple of years the Operating Margin of PEN has declined.
PEN has a better Gross Margin (66.47%) than 71.20% of its industry peers.
PEN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.45% | ||
| PM (TTM) | 11.54% | ||
| GM | 66.47% |
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
2. Health
2.1 Basic Checks
PEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PEN has less shares outstanding
The number of shares outstanding for PEN has been increased compared to 5 years ago.
The debt/assets ratio for PEN has been reduced compared to a year ago.
2.2 Solvency
PEN has an Altman-Z score of 17.69. This indicates that PEN is financially healthy and has little risk of bankruptcy at the moment.
PEN's Altman-Z score of 17.69 is amongst the best of the industry. PEN outperforms 94.76% of its industry peers.
The Debt to FCF ratio of PEN is 0.15, which is an excellent value as it means it would take PEN, only 0.15 years of fcf income to pay off all of its debts.
PEN has a Debt to FCF ratio of 0.15. This is amongst the best in the industry. PEN outperforms 94.24% of its industry peers.
PEN has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
PEN has a better Debt to Equity ratio (0.02) than 69.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Altman-Z | 17.69 |
ROIC/WACC0.8
WACC8.77%
2.3 Liquidity
PEN has a Current Ratio of 6.75. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
PEN's Current ratio of 6.75 is amongst the best of the industry. PEN outperforms 85.34% of its industry peers.
PEN has a Quick Ratio of 4.04. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
PEN's Quick ratio of 4.04 is fine compared to the rest of the industry. PEN outperforms 73.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.75 | ||
| Quick Ratio | 4.04 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 41.53% over the past year.
The Earnings Per Share has been growing by 24.23% on average over the past years. This is a very strong growth
Looking at the last year, PEN shows a quite strong growth in Revenue. The Revenue has grown by 12.92% in the last year.
Measured over the past years, PEN shows a quite strong growth in Revenue. The Revenue has been growing by 16.89% on average per year.
EPS 1Y (TTM)41.53%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%34.37%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%13.38%
3.2 Future
The Earnings Per Share is expected to grow by 26.11% on average over the next years. This is a very strong growth
PEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.02% yearly.
EPS Next Y31.21%
EPS Next 2Y33.12%
EPS Next 3Y30.65%
EPS Next 5Y26.11%
Revenue Next Year14.71%
Revenue Next 2Y14.46%
Revenue Next 3Y14.21%
Revenue Next 5Y13.02%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 72.82, PEN can be considered very expensive at the moment.
Based on the Price/Earnings ratio, PEN is valued a bit cheaper than the industry average as 65.97% of the companies are valued more expensively.
PEN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.38.
Based on the Price/Forward Earnings ratio of 50.26, the valuation of PEN can be described as expensive.
PEN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PEN is cheaper than 68.59% of the companies in the same industry.
PEN is valuated expensively when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 72.82 | ||
| Fwd PE | 50.26 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 65.97% of the companies listed in the same industry.
PEN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PEN is cheaper than 74.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 61.68 | ||
| EV/EBITDA | 54.09 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of PEN may justify a higher PE ratio.
PEN's earnings are expected to grow with 30.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.33
PEG (5Y)3.01
EPS Next 2Y33.12%
EPS Next 3Y30.65%
5. Dividend
5.1 Amount
PEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
255.6
-2.15 (-0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners91.21%
Inst Owner Change-2.3%
Ins Owners3.58%
Ins Owner Change11.8%
Market Cap9.97B
Analysts82.61
Price Target318.84 (24.74%)
Short Float %4.77%
Short Ratio3.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.74%
Min EPS beat(2)3.63%
Max EPS beat(2)23.86%
EPS beat(4)4
Avg EPS beat(4)14.23%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)16.41%
EPS beat(12)12
Avg EPS beat(12)26.69%
EPS beat(16)13
Avg EPS beat(16)15.8%
Revenue beat(2)2
Avg Revenue beat(2)2.12%
Min Revenue beat(2)1.67%
Max Revenue beat(2)2.56%
Revenue beat(4)4
Avg Revenue beat(4)1.18%
Min Revenue beat(4)0.22%
Max Revenue beat(4)2.56%
Revenue beat(8)6
Avg Revenue beat(8)0.49%
Revenue beat(12)9
Avg Revenue beat(12)0.89%
Revenue beat(16)12
Avg Revenue beat(16)1.37%
PT rev (1m)-0.25%
PT rev (3m)-1.99%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)-5.01%
EPS NY rev (1m)-1%
EPS NY rev (3m)-1.75%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.38%
Revenue NY rev (1m)0.8%
Revenue NY rev (3m)0.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 72.82 | ||
| Fwd PE | 50.26 | ||
| P/S | 7.79 | ||
| P/FCF | 61.68 | ||
| P/OCF | 49.47 | ||
| P/B | 7.7 | ||
| P/tB | 8.9 | ||
| EV/EBITDA | 54.09 |
EPS(TTM)3.51
EY1.37%
EPS(NY)5.09
Fwd EY1.99%
FCF(TTM)4.14
FCFY1.62%
OCF(TTM)5.17
OCFY2.02%
SpS32.82
BVpS33.18
TBVpS28.73
PEG (NY)2.33
PEG (5Y)3.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 11.41% | ||
| ROCE | 10.5% | ||
| ROIC | 7.05% | ||
| ROICexc | 9.79% | ||
| ROICexgc | 11.64% | ||
| OM | 12.45% | ||
| PM (TTM) | 11.54% | ||
| GM | 66.47% | ||
| FCFM | 12.63% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexcg growth 3Y49.31%
ROICexcg growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score9
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Debt/EBITDA | 0.12 | ||
| Cap/Depr | 209.19% | ||
| Cap/Sales | 3.11% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 112.96% | ||
| Profit Quality | 109.42% | ||
| Current Ratio | 6.75 | ||
| Quick Ratio | 4.04 | ||
| Altman-Z | 17.69 |
F-Score9
WACC8.77%
ROIC/WACC0.8
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.53%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%34.37%
EPS Next Y31.21%
EPS Next 2Y33.12%
EPS Next 3Y30.65%
EPS Next 5Y26.11%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%13.38%
Revenue Next Year14.71%
Revenue Next 2Y14.46%
Revenue Next 3Y14.21%
Revenue Next 5Y13.02%
EBIT growth 1Y48.52%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year76.66%
EBIT Next 3Y40.36%
EBIT Next 5Y28.33%
FCF growth 1Y31590.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y979.8%
OCF growth 3Y160.78%
OCF growth 5Y44.6%